This group also investigated the effect of MycERT2 activation on angiogenesis and the tumour microenvironment, revealing that Myc governed processes such as inflammation and angiogenesis through its non-cell-autonomous effectors, IL-23 and CCL9, which induce microenvironment alterations. This evidence concerns the gene MYC and neoplasm.